Center for Financial Planning’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-50
Closed -$489 – 602
2024
Q2
$489 Hold
50
– – ﹤0.01% 552
2024
Q1
$755 Hold
50
– – ﹤0.01% 565
2023
Q4
$1.08K Hold
50
– – ﹤0.01% 479
2023
Q3
$930 Hold
50
– – ﹤0.01% 482
2023
Q2
$1.27K Hold
50
– – ﹤0.01% 513
2023
Q1
$1.29K Hold
50
– – ﹤0.01% 474
2022
Q4
$1.18K Hold
50
– – ﹤0.01% 481
2022
Q3
$1K Hold
50
– – ﹤0.01% 619
2022
Q2
$2K Hold
50
– – ﹤0.01% 482
2022
Q1
$4K Hold
50
– – ﹤0.01% 447
2021
Q4
$5K Hold
50
– – ﹤0.01% 435
2021
Q3
$6K Sell
50
-38
-43% -$5.53K ﹤0.01% 404
2021
Q2
$15K Buy
88
+38
+76% +$6.16K ﹤0.01% 329
2021
Q1
$9K Hold
50
– – ﹤0.01% 401
2020
Q4
$10K Buy
+50
New +$10.2K ﹤0.01% 345

Other funds holding TDOC

Center for Financial Planning's TDOC Position: Q3 2024 in Review

Center for Financial Planning sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 50 shares — an estimated $489 sold.

Center for Financial Planning first reported a position in TDOC in Q4 2020 and held it in 15 quarters. The position peaked at $15K in Q2 2021. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Center for Financial Planning reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Center for Financial Planning sold 50 Teladoc Health shares in Q3 2024, an estimated $489.
  • Center for Financial Planning first reported a position in Teladoc Health in Q4 2020 and held it in 15 quarters.
  • Center for Financial Planning's Teladoc Health position peaked at $15K in Q2 2021.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Center for Financial Planning's 13F filing for Q3 2024, filed 16 Oct 2024.